Mr. Yaghmaie's practice entails the representation of private and publicly-held emerging growth high technology and life science companies, leading investment banks and venture capital funds, with a particular focus on private placements and venture financings, public offerings of equity and debt securities, and mergers and acquisitions. Mr. Yaghmaie has played an instrumental role in many of the leading technology transactions in New York's Silicon Alley, and regularly represents numerous venture-backed companies and venture capital funds. In addition, Mr. Yaghmaie has been involved in more than 30 public offerings, including public offerings by Albany Molecular Research, Best Software, Emcore, Globix, Knight/Trimark, Myriad Genetics, Predictive Systems, StarMedia and Tellium. Mr. Yaghmaie regularly advises Credit Suisse First Boston, Goldman Sachs & Co., Morgan Stanley and other technology-focused investment banks.

Mr. Yaghmaie has participated as a faculty of the Practicing Law Institute and has authored the chapter in the Securities Filings volume entitled, "Compliance with the Securities Act in the Acquisition Context." Mr. Yaghmaie is also a contributing editor of VC Experts' Venture Capital Encyclopedia and a member of the Advisory Board of the Silicon Alley Entrepreneurs Club.

Before joining Pillsbury, Mr. Yaghmaie was a co-founding partner of the New York office of Wilson Sonsini Goodrich & Rosati. Mr. Yaghmaie holds a J.D. from Boston University School of Law and a B.A. from Emory University.

Education
J.D., Boston University School of Law

B.A., Emory University

Affiliations
Admitted to practice: State of New York